IP Verse

Regeneron Pharmaceuticals vs. Amgen - CC_586764/2023

The case CC_586764/2023 was filed by the plaintiff Regeneron Pharmaceuticals against the defendant Amgen on 10 Nov, 2023. The case decision was made on Jul 16, 2024.

Case Timeline

10 Nov, 2023
Case Filed
24 Jan, 2024
Counterclaim for Revocation
04 Apr, 2024
Written Procedure
19 Apr, 2024
Oral Procedure
Jul 16, 2024
Decision

Case Details

    Case Number:

    CC_586764/2023

    Patent Number:

    EP3666797

    Filing Date:

    10 Nov, 2023

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Regeneron Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.

    Plaintiff Representative:

    • Niels Hoelder

    Defendants:

    • Amgen
    • Amgen Inc.

    Defendant Representative:

    • Johannes Heselberger

    Judges:

    • Andras Kupecz
    • Casper Struve
    • Ulrike Voß

    Court Division:

    First Instance, Central Division - Munich

Case Decision

    Decision Date:

    Jul 16, 2024

    Decision Document:

    View document

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Oct 23, 2024Procedural Order App 47154
Jul 16, 2024Final Order Anonymised
Jul 16, 2024Decision Revocation Counterclaim 14
Jul 16, 2024Decisionoutcome
Jul 4, 2024Announcement
Jun 6, 2024Recording Of Oral Hearing Placeholder
May 22, 2024Interimprocedureclosure
May 13, 2024Receipt
May 10, 2024Amgen Slides
May 10, 2024Amgen R 9 Appl Filing Slides
May 10, 2024.05.10 Sanofi And Regeneron Slides Signed
May 10, 2024.05.10 Sanofi And Regeneron Slide Reference Table Signed
May 10, 2024.05.10 Cover Letter Accompanying Slides Signed
May 7, 2024Receipt
May 7, 2024Outcome Of The Order
May 7, 2024Order Extension Slides
May 6, 2024Extension Request
Apr 30, 2024Outcome Of The Order
Apr 30, 2024Order Closing Workflow
Apr 26, 2024Receipt
Apr 26, 2024C54A Amgen Infringement Claim (En Translation)
Apr 26, 2024C37A US60 818234 (Priority Document To Bms Patent Application) (Signed)
Apr 26, 2024Annex 1 Updated Consolidated List Of Exhibits And Evidence (Signed)
Apr 26, 2024.04.26 Rop 9.1 Application Re C37A (Signed)
Apr 19, 2024Summons Oral Hearing
Apr 19, 2024Summons
Apr 19, 2024Hearing Dates
Apr 5, 2024Receipt
Apr 5, 2024Case Summary
Apr 5, 2024Annex 2 Notice Of Experts (Signed)
Apr 5, 2024Annex 1 CR OSS Reference Table (Signed)
Apr 5, 2024Amgen Cover Letter
Apr 5, 2024.04.05 Claimants Case Summary Signed
Apr 4, 2024Writtenprocedureclosure
Apr 4, 2024Template Order
Apr 4, 2024Order Re Dates
Apr 4, 2024Hearing Dates
Mar 21, 2024Amgen Response Cd To Sanofi Submission Re Pan Declaration
Mar 21, 2024Acknowledgement Of Lodging
Mar 12, 2024Reply To Amgen Defence To The Counterclaim For Invalidity
Mar 12, 2024Acknowledgement Of Lodging
Mar 7, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)
Feb 27, 2024Order To Combine Cases
Jan 25, 2024Formal Checks Notification Of Positive Outcome
Jan 25, 2024Acknowledgement Of Lodging
Jan 24, 2024Formal Checks Notification Of Positive Outcome
Jan 24, 2024Exhibit E6
Jan 24, 2024Exhibit E5
Jan 24, 2024Exhibit C30
Jan 24, 2024Exhibit Bp Cc03
Jan 24, 2024Exhibit Bp Cc02
Jan 24, 2024Exhibit Bp Cc01
Jan 24, 2024Exhibit Annex 2
Jan 24, 2024Defence To The Counterclaim For Revocation And Application To Amend The Patent Of Amgen
Jan 24, 2024D9 CR OOKE
Jan 24, 2024D94 Weider
Jan 24, 2024D93 Pan Declaration Pdfa
Jan 24, 2024D92 US8710192B2 (Novartis) Pdfa
Jan 24, 2024D8 Ni Et Al.
Jan 24, 2024D7 Kruth
Jan 24, 2024D6 WO2008 057457 A2
Jan 24, 2024D69 Examiner Notes About Irrelevance Of Tpos (27.3.)
Jan 24, 2024D68 Examiner Interview Notes Re Tpos (15.3.)
Jan 24, 2024D67 Examiner Interview Notes (1.3.)
Jan 24, 2024D66 Bell
Jan 24, 2024D65 Subramaniam
Jan 24, 2024D64 Choi
Jan 24, 2024D63 Spencer
Jan 24, 2024D62 Novotny 1983
Jan 24, 2024D61 Jia
Jan 24, 2024D60 Soto
Jan 24, 2024D5 WO2008 043753 A2
Jan 24, 2024D59 Hu
Jan 24, 2024D58 Paull
Jan 24, 2024D57 Nature Editorial
Jan 24, 2024D56 Parameswaran And Liu
Jan 24, 2024D55 Rudenko Full Validation Report
Jan 24, 2024D54 Degenst
Jan 24, 2024D53 Pedrioli And Oxenius
Jan 24, 2024D52 Perelson Weisbuch 1995
Jan 24, 2024D51 Raybould
Jan 24, 2024D50 Edwards
Jan 24, 2024D4 Kastelein
Jan 24, 2024D49 Rudenko
Jan 24, 2024D48 Baerga Ortiz
Jan 24, 2024D47 Glaser 1992
Jan 24, 2024D46 Maccallum 1996
Jan 24, 2024D45 Ye
Jan 24, 2024D44 Chowdhury 1999
Jan 24, 2024D43 Roberts 1987
Jan 24, 2024D42 US8357371B2
Jan 24, 2024D41 EP2358756B1
Jan 24, 2024D40 Declaration Of Wei Wang
Jan 24, 2024D40B Appb Wang Lnb
Jan 24, 2024D40A Appa Wang Lnb
Jan 24, 2024D3 Frank Kamenetsky Et Al.
Jan 24, 2024D39 Declaration Of Kelly Berry
Jan 24, 2024D38 Kondrashov
Jan 24, 2024D37 Rees
Jan 24, 2024D36 Baran
Jan 24, 2024D35 Lo Surdo
Jan 24, 2024D34 Eliassen
Jan 24, 2024D33 Esteve
Jan 24, 2024D32 Mitchell
Jan 24, 2024D31 Us 8 420 098 B2
Jan 24, 2024D30 Horton
Jan 24, 2024D2 US7737266B2 (Alnylam)
Jan 24, 2024D29 WO2008 1057797
Jan 24, 2024D28 Press Release Bms Isis
Jan 24, 2024D27 Poirier
Jan 24, 2024D26 Poirier
Jan 24, 2024D25 Mcnutt
Jan 24, 2024D24 US2009 0275053
Jan 24, 2024D23 Grefhorst
Jan 24, 2024D22 Ioannidis
Jan 24, 2024D21 Homer
Jan 24, 2024D20 Nassoury
Jan 24, 2024D1 Seeking Alpha Alnylam
Jan 24, 2024D19 Graham
Jan 24, 2024D18 Seidah
Jan 24, 2024D17 Maxwell
Jan 24, 2024D16 Horton
Jan 24, 2024D15 Lagace Supplemental Data To C3
Jan 24, 2024D14 Havel And Hamilton
Jan 24, 2024D13 Mccuskey
Jan 24, 2024D12 Brown And Goldstein 1979
Jan 24, 2024D11 Brown And Goldstein 1986
Jan 24, 2024D10 Bell
Jan 24, 2024Ar1 17 (Marked) Signed
Jan 24, 2024Ar1 17 (Clean) Signed
Jan 24, 2024Acknowledgement Of Lodging
Jan 9, 2024Acknowledgement Of Access To Case
Dec 20, 2023Zustellnachweis
Dec 20, 2023Notification Of Service
Dec 5, 2023Epouploaddocumentsworkflow
Dec 5, 2023Document From Epo
Dec 1, 2023Letter For Service
Nov 30, 2023Panel Appointment
Nov 24, 2023W9
Nov 24, 2023W8
Nov 24, 2023W7
Nov 24, 2023W64
Nov 24, 2023W63
Nov 24, 2023W62
Nov 24, 2023W61
Nov 24, 2023W60
Nov 24, 2023W6
Nov 24, 2023W59
Nov 24, 2023W58
Nov 24, 2023W57
Nov 24, 2023W56
Nov 24, 2023W55
Nov 24, 2023W54
Nov 24, 2023W53
Nov 24, 2023W52
Nov 24, 2023W51
Nov 24, 2023W50
Nov 24, 2023W5
Nov 24, 2023W49
Nov 24, 2023W48
Nov 24, 2023W47
Nov 24, 2023W46
Nov 24, 2023W45
Nov 24, 2023W44
Nov 24, 2023W43
Nov 24, 2023W42
Nov 24, 2023W41
Nov 24, 2023W40
Nov 24, 2023W4
Nov 24, 2023W39
Nov 24, 2023W38
Nov 24, 2023W37
Nov 24, 2023W36
Nov 24, 2023W35
Nov 24, 2023W34
Nov 24, 2023W33
Nov 24, 2023W32
Nov 24, 2023W31
Nov 24, 2023W30
Nov 24, 2023W3
Nov 24, 2023W29
Nov 24, 2023W28
Nov 24, 2023W27
Nov 24, 2023W26
Nov 24, 2023W25
Nov 24, 2023W24
Nov 24, 2023W23
Nov 24, 2023W22
Nov 24, 2023W21
Nov 24, 2023W20
Nov 24, 2023W2
Nov 24, 2023W19
Nov 24, 2023W18
Nov 24, 2023W17
Nov 24, 2023W16
Nov 24, 2023W15
Nov 24, 2023W14A
Nov 24, 2023W14
Nov 24, 2023W13
Nov 24, 2023W12
Nov 24, 2023W11
Nov 24, 2023W10
Nov 24, 2023W1
Nov 24, 2023Revocation Counerclaim
Nov 24, 2023Proof Of Payment
Nov 24, 2023Formal Checks Notification Of Positive Outcome
Nov 24, 2023Epo Request For Case Pending
Nov 24, 2023E4
Nov 24, 2023E3
Nov 24, 2023E2
Nov 24, 2023E1
Nov 24, 2023Correction Of Formalities
Nov 24, 2023Acknowledgement Of Lodging
Nov 14, 2023Formal Checks Request For Correction
Nov 10, 2023W9
Nov 10, 2023W8
Nov 10, 2023W7
Nov 10, 2023W64
Nov 10, 2023W63
Nov 10, 2023W62
Nov 10, 2023W61
Nov 10, 2023W60
Nov 10, 2023W6
Nov 10, 2023W59
Nov 10, 2023W58
Nov 10, 2023W57
Nov 10, 2023W56
Nov 10, 2023W55
Nov 10, 2023W54
Nov 10, 2023W53
Nov 10, 2023W52
Nov 10, 2023W51
Nov 10, 2023W50
Nov 10, 2023W5
Nov 10, 2023W49
Nov 10, 2023W48
Nov 10, 2023W47
Nov 10, 2023W46
Nov 10, 2023W45
Nov 10, 2023W44
Nov 10, 2023W43
Nov 10, 2023W42
Nov 10, 2023W41
Nov 10, 2023W40
Nov 10, 2023W4
Nov 10, 2023W39
Nov 10, 2023W38
Nov 10, 2023W37
Nov 10, 2023W36
Nov 10, 2023W35
Nov 10, 2023W34
Nov 10, 2023W33
Nov 10, 2023W32
Nov 10, 2023W31
Nov 10, 2023W30
Nov 10, 2023W3
Nov 10, 2023W29
Nov 10, 2023W28
Nov 10, 2023W27
Nov 10, 2023W26
Nov 10, 2023W25
Nov 10, 2023W24
Nov 10, 2023W23
Nov 10, 2023W22
Nov 10, 2023W21
Nov 10, 2023W20
Nov 10, 2023W2
Nov 10, 2023W19
Nov 10, 2023W18
Nov 10, 2023W17
Nov 10, 2023W16
Nov 10, 2023W15
Nov 10, 2023W14A
Nov 10, 2023W14
Nov 10, 2023W13
Nov 10, 2023W12
Nov 10, 2023W11
Nov 10, 2023W10
Nov 10, 2023W1
Nov 10, 2023Revocation Counerclaim
Nov 10, 2023Proof Of Payment
Nov 10, 2023E4
Nov 10, 2023E3
Nov 10, 2023E2
Nov 10, 2023E1

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Redacted Natural Person NameAmgen, Dehns, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34318/2025Aug 5, 2025Regeneron Pharmaceuticals -
APP_33251/2025Jul 21, 2025Regeneron Pharmaceuticals -
APL_32715/2025Jul 14, 2025Regeneron PharmaceuticalsAmgen, Amgen Europe

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -